Tag:
Loramyc
Latest Headlines
Latest Headlines
SpePharm demands $46.4M from BioAlliance Pharma
Amsterdam-based SpePharm Holding has filed a €35 million claim against BioAlliance Pharma for the "brutal termination" of a licensing agreement for the commercialization of the antifungal drug

